Abstract
Methotrexate has been widely used in the treatment of osterosarcoma, intracranial lymphomas and leukemia. However, patients are also at high risk of opportunist pathogens such as Aspergillus spp. infection for their deeply depressed immunity. The optimal choice of antifungal agents during the infection of Aspergillus for these patients is necessary to be explored. In this study, we investigated the interactions between antifungals and methotrexate against Aspergillus in vitro. A total of 23 clinical isolates of Aspergillus spp. were studied. Microdilution checkerboard technique was performed to evaluate the interaction of methotrexate with voriconazole, itraconazole, terbinafine and amphotericin B. The highest rate of synergy was obtained for the combination of terbinafine and methotrexate, which exhibited synergy against 60.9% (14/23) of strains. No interaction was detected for the combinations of methotrexate plus itraconazole or amphotericin B against 95.7% (22/23) or 100% of strains, respectively. Although voriconazole exhibited indifferent against 87% (20/23) of strains when combined with methotrexate, antagonism effect was found against 13% (3/23) of strains. The positive interactions of terbinafine and methotrexate were also certified by disk diffusion assay. In addition, we observed the morphological changes for the interaction of methotrexate with terbinafine against Aspergillus. Further inhibition and distortion of growth were found after the combination of terbinafine and methotrexate compared with the drugs treated alone. Clinical studies are warranted to further elucidate optimal treatments for the immucompromised patients with Aspergillus infection.
Similar content being viewed by others
References
Warnock DW, Oliver DA, Cheung MM, Zurick NJ. Effect of methotrexate on the germination and growth of Aspergillus fumigatus and Aspergillus flavus strains. J Antimicrob Chemother. 1992;29:375–81.
Gottfredsson M, Steingrimsdottir H. Disseminated invasive aspergillosis in a patient with acute leukaemia. Acta Biomed. 2006;77(Suppl 2):10–3.
Kristan SS, Kern I, Music E. Invasive pulmonary aspergillosis. Respiration. 2002;69(6):521–5.
Chamilos G, Lewis RE, Lamaris G, Walsh TJ, Kontoyiannis DP. Zygomycetes hyphae trigger an early, robust proinflammatory response in human polymorphonuclear neutrophils through toll-like receptor 2 induction but display relative resistance to oxidative damage. Antimicrob Agents Chemother. 2008;52:722–4.
Odds FC. Synergy, antagonism, what the chequerboard puts between them. J Antimicrob Chemother. 2003;52:1.
Cruz MC, Goldstein AL, Blankenship J, et al. Rapamycin and less immunosuppressive analogs are toxic to Candida albicans and Cryptococcus neoformans via FKBP12-dependent inhibition of TOR. Antimicrob Agents Chemother. 2001;45:3162–70.
Steinbach WJ, Schell WA, Blankenship JR, Onyewu C, Heitman J, Perfect JR. In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus. Antimicrob Agents Chemother. 2004;48:1664–9.
Treon SP, Chabner BA. Concepts in use of high-dose methotrexate therapy. Clin Chem. 1996;42:1322–9.
Warnock DW, Johnson EM, Burke J, Pracharktam R. Effect of methotrexate alone and in combination with antifungal drugs on the growth of Candida albicans. J Antimicrob Chemother. 1989;23:837–47.
Garcia-Effron G, Gomez-Lopez A, Mellado E, Monzon A, Rodriguez-Tudela JL, Cuenca-Estrella M. In vitro activity of terbinafine against medically important non-dermatophyte species of filamentous fungi. J Antimicrob Chemother. 2004;53:1086–9.
Mosquera J, Sharp A, Moore CB, Warn PA, Denning DW. In vitro interaction of terbinafine with itraconazole, fluconazole, amphotericin B and 5-flucytosine against Aspergillus spp. J Antimicrob Chemother. 2002;50:189–94.
Schiraldi GF, Cicero SL, Colombo MD, Rossato D, Ferrarese M, Soresi E. Refractory pulmonary aspergillosis: compassionate trial with terbinafine. Br J Dermatol. 1996;134(46):25–9. Discussion 39–40.
Li DM, Xiu DR, Li RY, Samson RA, de Hoog GS, Wang DL. Aspergillus flavus myositis in a patient after liver transplantation. Clin Transplant. 2008;22:508–11.
Conflicts of Interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yang, J., Wan, Z., Wang, X. et al. In Vitro Interactions Between Antifungals and Methotrexate Against Aspergillus spp.. Mycopathologia 168, 237–242 (2009). https://doi.org/10.1007/s11046-009-9218-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11046-009-9218-4